You are currently not accessing the Inpatient Hospital Pharmacy Free Trial Program (FTP) portal with Google Chrome. For optimal user experience, please log in to the FTP portal using Google Chrome as your browser. Thank you.
  • For US Healthcare Professionals Only

INVEGA SUSTENNA® (paliperidone palmitate) is indicated for Schizophrenia and Schizoaffective disorder in adults

Schizophrenia and Schizoaffective disorder

INPATIENT HOSPITAL PHARMACY FREE TRIAL PROGRAM

THE INPATIENT HOSPITAL PHARMACY FREE TRIAL PROGRAM
CLICK HERE

Please see below for an overview of the program rules for the INVEGA SUSTENNA® Inpatient Hospital Pharmacy Free Trial Program. In order to receive free trial units for your patients, you must agree and adhere to all program rules, which can be found on the website upon login.

ELIGIBILITY

  • The free trial product requested must be for an inpatient hospital licensed as a hospital under applicable state law.
  • The program is only available for an inpatient hospital that is unable to accept PDMA samples.
  • Retail pharmacies are not eligible for program participation.
  • There is no requirement for subsequent use of INVEGA SUSTENNA® for any patient receiving a free trial unit.
  • Program terms expire at the end of each calendar year. Program available only in the United States and Puerto Rico.*

ANNUAL ENROLLMENTS

  • Annual enrollment is required with valid state license numbers from at least one of each of the following:
    • (1) inpatient hospital pharmacist
    • (2) inpatient hospital pharmacy
    • (3) inpatient hospital
    • (4) inpatient hospital prescriber

PATIENT & PRESCRIBER QUANTITY LIMITS

  • For patients determined to be appropriate, pharmacists may order and receive up to 2 free trial units per calendar year per patient.
  • Inpatient hospital pharmacies and inpatient hospitals must have the ability to track utilization of this program by each patient and establish adequate controls to ensure that product received under this program is appropriately segregated and tracked as if it were a PDMA sample.
  • Additional quantity limits may apply.

PROHIBITION ON SEPARATE BILLING

  • Free trial units are commercially labeled as trade products and not labeled as sample products.
  • Do not separately bill the patient, the patient's insurance carrier, or the government for any INVEGA SUSTENNA® dispensed as part of this program.
  • Free trial product received pursuant to this program may not be sold, traded, bartered, or returned for credit.

DISPENSE DATE

  • Orders requesting free trial units must be submitted within 30 days of the dispense date.

PHARMACIST ACKNOWLEDGMENT OF RECEIPT (AOR)

  • Failure to complete AOR{s) within a timely manner will result in suspension of the program.

TRANSPARENCY

  • Hospital, pharmacy, pharmacist, and prescriber information and the free trial disbursement{s) may be reported as required by state or federal law. Once reported, this information may be made available for public view.

*Janssen Pharmaceuticals, Inc., may terminate the program prior to the end of each calendar year, upon 60 days' notice to all participating inpatient pharmacies, or upon less or no notice if there is a change in interpretation of federal or stale laws supporting the continuation of the program.

Shipments will not be processed Friday through Sunday or on holidays. These factors may result in a delay in shipment. For questions about this program or if you no longer wish to participate, please call 800-240-5746, Monday through Friday, between 8 AM and 8 PM ET.